FindTrial
Sign In

The study on clinical application of modified nasolacrimal stent and sparable lacrimal stent

The study on clinical application of modified nasolacrimal stent and sparable lacrimal stent

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042657
Enrollment
Unknown
Registered
2021-01-25
Start date
2020-12-16
Completion date
Unknown
Last updated
2021-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstruction of Lacrimal Passage

Interventions

Experimental group:RT stent implantation
Control group:Bicanalicular stent implantation

Sponsors

Third Medical Center of PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Experimental group and control group in the patient have to surgical indications of progress; (2) Patients with normal mental.

Exclusion criteria

Exclusion criteria: (1) Poor cooperations or unable to accurately describe the problem; (2) Serious nasal deformity, eye or nasal tumors; (3) Lacrimal duct obstruction caused by trauma; (4) Cannot tolerate surgery.

Design outcomes

Primary

MeasureTime frame
Cure rate;—

Countries

China

Contacts

Public ContactTao Hai

Third Medical Center of PLA General Hospital

taohaiwj@sina.com+86 13691446988

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026